The Roadmap ensures we have a strong focus on eliminating inequities, meeting our commitments to Te Tiriti o Waitangi, ensuring timely access to quality care and placing the needs of people with live experience of rheumatic fever and rheumatic heart disease at the heart of our efforts.

How are we doing?

In 2023, there were 182 people admitted to hospital for the first time with rheumatic fever (3.5 per 100,000) in New Zealand. This is an increase from 84 people in 2022 (1.6 per 100,000). 

First episode rheumatic fever hospitalisations, annual rate per 100,000, New Zealand, 2006 – 2023

The graph above shows the rate of people admitted to hospital with rheumatic fever for the first time from calendar years 2006 to 2023. The graph above shows the rate of people admitted to hospital with rheumatic fever for the first time from calendar years 2006 to 2023. The graph above shows the rate of people admitted to hospital with rheumatic fever for the first time from calendar years 2006 to 2023.

The graph above shows the rate of people admitted to hospital with rheumatic fever for the first time from calendar years 2006 to 2023.

The graph above shows the rate of people admitted to hospital with rheumatic fever for the first time from calendar years 2006 to 2023.

First episode rheumatic fever hospitalisations, annual rate per 100,000, by ethnic group, New Zealand, 2006 - 2023

The graph above shows the rate of people admitted to hospital with rheumatic fever for the first time from calendar years 2006 to 2023 by ethnicity. The graph above shows the rate of people admitted to hospital with rheumatic fever for the first time from calendar years 2006 to 2023 by ethnicity. The graph above shows the rate of people admitted to hospital with rheumatic fever for the first time from calendar years 2006 to 2023 by ethnicity.

The graph above shows the rate of people admitted to hospital with rheumatic fever for the first time from calendar years 2006 to 2023 by ethnicity.

The graph above shows the rate of people admitted to hospital with rheumatic fever for the first time from calendar years 2006 to 2023 by ethnicity.

Following a decrease between years 2011 to 2016, there was a stabilisation in the rate of Māori admitted to hospital for the first time with rheumatic fever between 2016 and 2020. Since 2020, Māori rates have decreased from 8.7 per 100,000 (74 cases) in 2020 to 5.5 per 100,000 (49 cases) in 2022 (5.5 per 100,000). This represents an approximately 34% decrease in cases since 2020. However there has been an increase in rates to 8.4 per 100,000 (76 cases) in the year 2023.

Hospitalisations for Pacific people fluctuated between 2011 and 2019, however there has been a large decrease in Pacific people admitted to hospital for the first time with rheumatic fever since 2020. Since 2020, Pacific rates have decreased from 19.5 per 100,000 (69 cases) in 2020 to 8.2 per 100,000 (30 cases) in 2022. This represents an approximately 57% decrease in cases since 2020. This decrease has been largely driven by a reduction in hospitalisations for Pacific people in Counties Manukau. However, there has been an increase in rates to 25.6 per 100,000 (94 cases) in the year 2023.

An insights report was completed in 2024, which provided analysis of rheumatic fever and rheumatic heart disease through the COVID-19 pandemic in New Zealand. This work was led by Tōmaiora, researchers from the University of Auckland. Key findings included significant decreases in crude acute rheumatic fever hospitalisation rates in 2021-2022, however marked inequities still persisted for Māori and Pacific peoples. The COVID-19 elimination-suppression strategy had a significant independent effect in a best fit model, associated with a reduction in acute rheumatic fever hospitalisations by 50%.

It is not surprising to see an increase in rheumatic fever hospitalisations, given what has occurred with other childhood respiratory infections (viral, invasive pneumococcal disease etc.) during the pandemic, with infection rates initially falling then now rising again. Health New Zealand will continue to watch the situation closely.

It is also important to note that while Aotearoa has a high incidence of rheumatic fever, the annual numbers are small. . Therefore, changes year-to-year may be real, or they may be an artifact of the variability that is seen when there are small numbers of cases.

The following table shows the numbers and rates of people being admitted to hospital with rheumatic fever for the first time in 2023 by age group. It shows that the majority of cases continue to occur in children between 5 and 14 years.

First episode rheumatic fever hospitalisations, rate per 100,000, by age group, 2023

The table below details the rheumatic fever rates in 2023 by age group.

 

Numbers

Rate per 100,000

0–4 years

1

0.3

5–14 years

110

16.5

15–24 years

40

6.1

25–44 years

27

1.8

45+ years

4

0.2

First episode rheumatic fever hospitalisations, rate per 100,000, by Health District, 2023

The table below details the rheumatic fever rates in 2023 by health districts.

Health District

(formerly DHB region)

Numbers

Rate per 100,000

Northland

5

1.0

Waitemata

14

2.2

Auckland

17

3.5

Counties Manukau

79

12.7

Waikato

13

2.8

Lakes

5

4.2

Bay of Plenty

10

3.6

Hauora Tairāwhiti

4

-

Taranaki

4

3.1

Hawke’s Bay

7

3.8

Midcentral

<4

-

Whanganui

<4

0.0

Capital & Coast

6

1.8

Hutt Valley

11

6.8

Wairarapa

0

-

Southern region

0

-

Source: National Minimum Dataset

Note: Rates have not been calculated where there were fewer than four cases. This is because the small numbers will result in unreliable estimates of rates.

Where to from here?

A five-year Rheumatic Fever Roadmap was launched in June 2023. The purpose of the Roadmap is to reset and refocus efforts around rheumatic fever and rheumatic heart disease prevention, identification and management, and sets out existing and new priority actions and opportunities for investment in the coming years. 

The three focus areas of the Roadmap include:

  1. Whānau Ora – determinants of wellbeing and primary prevention.
  2. Tāngata Ora – quality health care and improved journey through the health system for those with rheumatic heart disease and rheumatic fever.
  3. Kōkiri Ngātahi – system readiness and change.

 

The Roadmap is available below.

Download: Rheumatic Fever Roadmap, 2023 - 2028 - PDF, 9.3 MB

The Rheumatic Fever Roadmap, 2023 – 2028 has been developed to reset, renew and amplify efforts in Aotearoa New Zealand to tackle rheumatic fever.

Download: Rheumatic Fever Report 2023 - XLSX, 729 KB

Rates and numbers are available for the New Zealand population, by ethnic group and for health district..